Top compounds associated with response to CIC


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 3e-11
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.24 2e-10
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.22 5e-10
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 6e-10
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.32 9e-10
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.19 1e-09
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.22 7e-09
mRNA PX-12 CTRPv2 pan-cancer AAC 0.16 3e-08
Download CSV